The possible role of Dickkopf-1, Golgi protein- 73 and Midkine as predictors of hepatocarcinogenesis: a review and an Egyptian study
Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death worldwide. The use of alpha fetoprotein (AFP) alone was not an accurate biomarker for HCC despite its high specificity. Therefore, we assessed the possible role of serum biomarkers that have been mentioned briefly...
Saved in:
Published in | Scientific reports Vol. 10; no. 1; p. 5156 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
20.03.2020
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death worldwide. The use of alpha fetoprotein (AFP) alone was not an accurate biomarker for HCC despite its high specificity. Therefore, we assessed the possible role of serum biomarkers that have been mentioned briefly in previous studies on Egyptian patients ion top of HCV. However these studies included small number of patients and did not assess the different stages of hepatocarcinogenesis. In the current study we assessed 1) the expression levels of Golgi protein 37(GP73),Midkine (MDK) and Dickkopf-1(DKK-1) proteins separately and in combination at different stages of hepatocarcinogenesis. GP73, MDK and DKK-1 proteins were assessed in 238 individuals divided into 4 groups (HCC, chronic HCV, and chronic HCV with cirrhosis and healthy subjects as a control) Serum levels of GP73, MDK, and DKK-1 were assessed in all subjects by ELISA. Serum levels of the studied markers were significantly higher in HCC compared to other groups (p < 0.001). The ROC curve analysis for the studied markers showed 1) 88.5% sensitivity, 80.6% specificity, 69% PPV, 93.5% NPV and (AUC 0.91)for MDK; 2) 93.6%, 86.9%, 77.7%, 96.5% for DKK-1. 3) 91%, 85%, 74.7%, 95% (AUC 0.96) for GP73 and 4) 74.4%, 84.4%, 69.9%, 87.1% (AUC 0.81) for AFP. Serum levels of GP73, MDK, and DKK-1 are comparable to AFP as promising predictor biomarkers for HCC patients from Egypt. A two markers panel including Gp73 and DKK-1 showed the highest specificity and sensitivity among different markers combinations. |
---|---|
AbstractList | Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death worldwide. The use of alpha fetoprotein (AFP) alone was not an accurate biomarker for HCC despite its high specificity. Therefore, we assessed the possible role of serum biomarkers that have been mentioned briefly in previous studies on Egyptian patients ion top of HCV. However these studies included small number of patients and did not assess the different stages of hepatocarcinogenesis. In the current study we assessed 1) the expression levels of Golgi protein 37(GP73),Midkine (MDK) and Dickkopf-1(DKK-1) proteins separately and in combination at different stages of hepatocarcinogenesis. GP73, MDK and DKK-1 proteins were assessed in 238 individuals divided into 4 groups (HCC, chronic HCV, and chronic HCV with cirrhosis and healthy subjects as a control) Serum levels of GP73, MDK, and DKK-1 were assessed in all subjects by ELISA. Serum levels of the studied markers were significantly higher in HCC compared to other groups (p < 0.001). The ROC curve analysis for the studied markers showed 1) 88.5% sensitivity, 80.6% specificity, 69% PPV, 93.5% NPV and (AUC 0.91)for MDK; 2) 93.6%, 86.9%, 77.7%, 96.5% for DKK-1. 3) 91%, 85%, 74.7%, 95% (AUC 0.96) for GP73 and 4) 74.4%, 84.4%, 69.9%, 87.1% (AUC 0.81) for AFP. Serum levels of GP73, MDK, and DKK-1 are comparable to AFP as promising predictor biomarkers for HCC patients from Egypt. A two markers panel including Gp73 and DKK-1 showed the highest specificity and sensitivity among different markers combinations. Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death worldwide. The use of alpha fetoprotein (AFP) alone was not an accurate biomarker for HCC despite its high specificity. Therefore, we assessed the possible role of serum biomarkers that have been mentioned briefly in previous studies on Egyptian patients ion top of HCV. However these studies included small number of patients and did not assess the different stages of hepatocarcinogenesis. In the current study we assessed 1) the expression levels of Golgi protein 37(GP73),Midkine (MDK) and Dickkopf-1(DKK-1) proteins separately and in combination at different stages of hepatocarcinogenesis. GP73, MDK and DKK-1 proteins were assessed in 238 individuals divided into 4 groups (HCC, chronic HCV, and chronic HCV with cirrhosis and healthy subjects as a control) Serum levels of GP73, MDK, and DKK-1 were assessed in all subjects by ELISA. Serum levels of the studied markers were significantly higher in HCC compared to other groups (p < 0.001). The ROC curve analysis for the studied markers showed 1) 88.5% sensitivity, 80.6% specificity, 69% PPV, 93.5% NPV and (AUC 0.91)for MDK; 2) 93.6%, 86.9%, 77.7%, 96.5% for DKK-1. 3) 91%, 85%, 74.7%, 95% (AUC 0.96) for GP73 and 4) 74.4%, 84.4%, 69.9%, 87.1% (AUC 0.81) for AFP. Serum levels of GP73, MDK, and DKK-1 are comparable to AFP as promising predictor biomarkers for HCC patients from Egypt. A two markers panel including Gp73 and DKK-1 showed the highest specificity and sensitivity among different markers combinations.Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death worldwide. The use of alpha fetoprotein (AFP) alone was not an accurate biomarker for HCC despite its high specificity. Therefore, we assessed the possible role of serum biomarkers that have been mentioned briefly in previous studies on Egyptian patients ion top of HCV. However these studies included small number of patients and did not assess the different stages of hepatocarcinogenesis. In the current study we assessed 1) the expression levels of Golgi protein 37(GP73),Midkine (MDK) and Dickkopf-1(DKK-1) proteins separately and in combination at different stages of hepatocarcinogenesis. GP73, MDK and DKK-1 proteins were assessed in 238 individuals divided into 4 groups (HCC, chronic HCV, and chronic HCV with cirrhosis and healthy subjects as a control) Serum levels of GP73, MDK, and DKK-1 were assessed in all subjects by ELISA. Serum levels of the studied markers were significantly higher in HCC compared to other groups (p < 0.001). The ROC curve analysis for the studied markers showed 1) 88.5% sensitivity, 80.6% specificity, 69% PPV, 93.5% NPV and (AUC 0.91)for MDK; 2) 93.6%, 86.9%, 77.7%, 96.5% for DKK-1. 3) 91%, 85%, 74.7%, 95% (AUC 0.96) for GP73 and 4) 74.4%, 84.4%, 69.9%, 87.1% (AUC 0.81) for AFP. Serum levels of GP73, MDK, and DKK-1 are comparable to AFP as promising predictor biomarkers for HCC patients from Egypt. A two markers panel including Gp73 and DKK-1 showed the highest specificity and sensitivity among different markers combinations. Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death worldwide. The use of alpha fetoprotein (AFP) alone was not an accurate biomarker for HCC despite its high specificity. Therefore, we assessed the possible role of serum biomarkers that have been mentioned briefly in previous studies on Egyptian patients ion top of HCV. However these studies included small number of patients and did not assess the different stages of hepatocarcinogenesis. In the current study we assessed 1) the expression levels of Golgi protein 37(GP73),Midkine (MDK) and Dickkopf-1(DKK-1) proteins separately and in combination at different stages of hepatocarcinogenesis. GP73, MDK and DKK-1 proteins were assessed in 238 individuals divided into 4 groups (HCC, chronic HCV, and chronic HCV with cirrhosis and healthy subjects as a control) Serum levels of GP73, MDK, and DKK-1 were assessed in all subjects by ELISA. Serum levels of the studied markers were significantly higher in HCC compared to other groups (p < 0.001). The ROC curve analysis for the studied markers showed 1) 88.5% sensitivity, 80.6% specificity, 69% PPV, 93.5% NPV and (AUC 0.91)for MDK; 2) 93.6%, 86.9%, 77.7%, 96.5% for DKK-1. 3) 91%, 85%, 74.7%, 95% (AUC 0.96) for GP73 and 4) 74.4%, 84.4%, 69.9%, 87.1% (AUC 0.81) for AFP. Serum levels of GP73, MDK, and DKK-1 are comparable to AFP as promising predictor biomarkers for HCC patients from Egypt. A two markers panel including Gp73 and DKK-1 showed the highest specificity and sensitivity among different markers combinations. |
ArticleNumber | 5156 |
Author | Hassan, Reem Mostafa M. Lotfy, Mai Gabr, Reham Mohamed EL Kassas, Mohamed Abdel-zaher, Rania A. Talaat Bahnassy, Abeer A. Mohanad, Marwa N Zekri, Abdel-Rahman Ahmed, Ola S. Salam, El SayedTarekAbd El |
Author_xml | – sequence: 1 givenname: Abdel-Rahman surname: N Zekri fullname: N Zekri, Abdel-Rahman email: ncizekri@yahoo.com organization: Molecular Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University – sequence: 2 givenname: Mohamed surname: EL Kassas fullname: EL Kassas, Mohamed organization: Endemic Medicine Department, Faculty of Medicine, Helwan University – sequence: 3 givenname: El SayedTarekAbd El surname: Salam fullname: Salam, El SayedTarekAbd El organization: Botany and Microbiology Department, Faculty of Science, Cairo University – sequence: 4 givenname: Reem Mostafa orcidid: 0000-0002-7032-4735 surname: Hassan fullname: Hassan, Reem Mostafa organization: Clinical and Chemical Pathology Department, Faculty of Medicine, Cairo University – sequence: 5 givenname: Marwa surname: Mohanad fullname: Mohanad, Marwa organization: Biochemistry Department, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology – sequence: 6 givenname: Reham Mohamed surname: Gabr fullname: Gabr, Reham Mohamed organization: Molecular Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University – sequence: 7 givenname: Mai surname: M. Lotfy fullname: M. Lotfy, Mai organization: Molecular Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University – sequence: 8 givenname: Rania A. Talaat surname: Abdel-zaher fullname: Abdel-zaher, Rania A. Talaat organization: Botany and Microbiology Department, Faculty of Science, Cairo University – sequence: 9 givenname: Abeer A. surname: Bahnassy fullname: Bahnassy, Abeer A. organization: Molecular pathology unit, pathology Department, National Cancer Institute, Cairo University – sequence: 10 givenname: Ola S. surname: Ahmed fullname: Ahmed, Ola S. organization: Molecular Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32198440$$D View this record in MEDLINE/PubMed |
BookMark | eNp9Uk1v1DAUtFARLaV_gAOyxIVDA_5OwqESaktBKuJSzpbjvOy6m7WD7RTtnR-Ot9tC6aE-2E9-M6N5evMS7fngAaHXlLynhDcfkqCybSrCSKUYkbRSz9ABI0JWjDO296DeR0cpXZNyJGsFbV-gfc5o2whBDtDvqyXgKaTkuhFwDOUKAz5zdrUK01DRY3wRxoXDUwwZnK9wzbHxPf7m-pXzgE0qLeidzSGmLXUJk8nBmmidDwvwkFz6iA2OcOPg1y3XeHy-2EzZlSLlud-8Qs8HMyY4unsP0Y_P51enX6rL7xdfTz9dVlbUIlfQ1UrVQlo1dMrIWllaG6YILf92qEkLRgBpWtZJM9RG8F6QmvGB284M0g78EJ3sdKe5W0NvwedoRj1FtzZxo4Nx-v-Od0u9CDe6Jg1vCSsC7-4EYvg5Q8p67ZKFcTQewpw04w1VTLVSFujbR9DrMEdfxtuiCOFMMFpQbx46-mvlfkEF0OwANpYlRRi0ddlkF7YG3agp0ds46F0cdImDvo2DVoXKHlHv1Z8k8R0pFbBfQPxn-wnWH-NIx9E |
CitedBy_id | crossref_primary_10_1016_j_livres_2020_09_003 crossref_primary_10_1002_iub_2458 crossref_primary_10_1016_j_aohep_2023_101137 crossref_primary_10_1016_j_jpba_2022_115215 crossref_primary_10_1080_14737140_2022_2139681 crossref_primary_10_1080_17474124_2021_1900731 crossref_primary_10_3390_cancers15194850 crossref_primary_10_1186_s12876_023_02685_8 crossref_primary_10_3390_cells13020136 crossref_primary_10_3390_ijms24054286 crossref_primary_10_3390_jcm10050977 crossref_primary_10_1186_s13000_021_01150_y |
Cites_doi | 10.1016/S1499-3872(12)60160-X 10.19082/3492 10.1016/S1470-2045(12)70233-4 10.1016/j.clinbiochem.2014.08.010 10.1111/j.1572-0241.2006.00467.x 10.1016/S0009-8981(01)00644-1 10.1111/j.1572-0241.2004.40410.x 10.1002/ijc.25838 10.18632/oncotarget.14954 10.1053/j.gastro.2011.12.061 10.1136/gut.2010.214916 10.1007/s12016-017-8655-y 10.1016/j.apjtm.2017.03.016 10.1093/jnci/djn134 10.1155/2015/146389 10.1159/000320379 10.1007/s12032-014-0367-z 10.1155/2017/5358615 10.1158/0008-5472.CAN-09-3879 10.1371/journal.pone.0151069 10.1016/j.jhep.2012.04.018 10.1158/1078-0432.CCR-12-3363 10.1371/journal.pone.0155800 |
ContentType | Journal Article |
Copyright | The Author(s) 2020 This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s) 2020 – notice: This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88A 88E 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 5PM |
DOI | 10.1038/s41598-020-62051-6 |
DatabaseName | Springerlink CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability (subscription) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central ProQuest Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection ProQuest Health & Medical Collection Medical Database Science Database ProQuest Biological Science ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE MEDLINE - Academic Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2045-2322 |
ExternalDocumentID | PMC7083902 32198440 10_1038_s41598_020_62051_6 |
Genre | Research Support, Non-U.S. Gov't Journal Article Review |
GrantInformation_xml | – fundername: Science and Technology Development Fund (STDF) grantid: 5193; 5193; 5193; 5193; 5193; 5193; 5193 funderid: https://doi.org/10.13039/501100003009 – fundername: ; grantid: 5193; 5193; 5193; 5193; 5193; 5193; 5193 |
GroupedDBID | 0R~ 3V. 4.4 53G 5VS 7X7 88A 88E 88I 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AAKDD ABDBF ABUWG ACGFS ACSMW ACUHS ADBBV ADRAZ AENEX AEUYN AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO EBD EBLON EBS ESX FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE KQ8 LK8 M0L M1P M2P M48 M7P M~E NAO OK1 PIMPY PQQKQ PROAC PSQYO RNT RNTTT RPM SNYQT UKHRP AASML AAYXX AFPKN CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 7XB 8FK AARCD K9. PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS Q9U 7X8 5PM |
ID | FETCH-LOGICAL-c474t-eb766745c6fb6a576c17a2601b76cf709ea4e0892b5af7a43d40723f3cbaf5cf3 |
IEDL.DBID | M48 |
ISSN | 2045-2322 |
IngestDate | Thu Aug 21 14:30:45 EDT 2025 Fri Jul 11 16:15:36 EDT 2025 Wed Aug 13 10:55:32 EDT 2025 Thu Jan 02 22:56:54 EST 2025 Thu Apr 24 23:10:33 EDT 2025 Tue Jul 01 03:24:08 EDT 2025 Fri Feb 21 02:36:57 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c474t-eb766745c6fb6a576c17a2601b76cf709ea4e0892b5af7a43d40723f3cbaf5cf3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
ORCID | 0000-0002-7032-4735 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/s41598-020-62051-6 |
PMID | 32198440 |
PQID | 2380032421 |
PQPubID | 2041939 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7083902 proquest_miscellaneous_2381626955 proquest_journals_2380032421 pubmed_primary_32198440 crossref_citationtrail_10_1038_s41598_020_62051_6 crossref_primary_10_1038_s41598_020_62051_6 springer_journals_10_1038_s41598_020_62051_6 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2020-03-20 |
PublicationDateYYYYMMDD | 2020-03-20 |
PublicationDate_xml | – month: 03 year: 2020 text: 2020-03-20 day: 20 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Scientific reports |
PublicationTitleAbbrev | Sci Rep |
PublicationTitleAlternate | Sci Rep |
PublicationYear | 2020 |
Publisher | Nature Publishing Group UK Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
References | YanQNovel functional proteins interact with midkine in hepatic cancer cellsHepatobiliary Pancreat. Dis. Int.2012113272714161941:CAS:528:DC%2BC38XhtFWhtL%2FF10.1016/S1499-3872(12)60160-X BarreirosAPPiscagliaFDietrichCFContrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma (HCC): Comments on AASLD guidelinesJ. Hepatol.2012574930210.1016/j.jhep.2012.04.018 ShenQSerum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: A large-scale, multicentre studyLancet Oncol.2012138817261:CAS:528:DC%2BC38XhtFajsLnK10.1016/S1470-2045(12)70233-4 ColliAAccuracy of Ultrasonography, Spiral CT, Magnetic Resonance, and Alpha-Fetoprotein in Diagnosing Hepatocellular Carcinoma: A Systematic Review: CMEAm. J. Gastroenterol.20061013513231:CAS:528:DC%2BD28XjtlGhsLs%3D10.1111/j.1572-0241.2006.00467.x LiuTSerum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinomaOncotarget201781016498506281577055369980 Shaheen, K. Y. A., Abdel-Mageed, A. I., Safwat, E., Albreedy, A. M. The value of serum midkine level in diagnosis of hepatocellular carcinoma. Int. J. Hepatol. 1–5, (2015). HodeibHELshoraOSelimAMohammed SabryNMohamed EL-ashryHSerum Midkine and Osteopontin Levels as Diagnostic Biomarkers of Hepatocellular CarcinomaElectron. physician2017913492810.19082/3492 ZhuWWEvaluation of midkine as a diagnostic serum biomarker in hepatocellular carcinomaClin. Cancer Res.201319143944541:CAS:528:DC%2BC3sXhtFSrtbfP10.1158/1078-0432.CCR-12-3363 SongPTangWKokudoNSerum biomarkers for early diagnosis of hepatocellular carcinomaTransl. Gastrointest. Cancer20143210351:CAS:528:DC%2BC28Xhtlyiu7vO MaoYGolgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinomaGut201059121687931:CAS:528:DC%2BC3MXpvFCr10.1136/gut.2010.214916 Ferlay, J. et al. Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Lyon, France. GLOBOCAN v1.0. Int Agency Res Cancer. Available from: http://globocan.iarc.fr (2012). MaitraAThuluvathPJGP73 and liver disease: a (Golgi) complex enigmaAm. J. Gastroenterol.20049961096810.1111/j.1572-0241.2004.40410.x TianLSerological AFP/Golgi protein 73 could be a new diagnostic parameter of hepatic diseasesInt. J. Cancer201112981923311:CAS:528:DC%2BC3MXhtVKlsrrK10.1002/ijc.25838 GeTDiagnostic values of alpha-fetoprotein, dickkopf-1, and osteopontin for hepatocellular carcinomaMed. Oncol.201532310.1007/s12032-014-0367-z LlovetJMDesign and endpoints of clinical trials in hepatocellular carcinomaJ. Natl Cancer Inst.20081001069871110.1093/jnci/djn134 ÖzkanHDiagnostic and Prognostic Validity of Golgi Protein 73 in Hepatocellular CarcinomaDigestion2011831–283810.1159/000320379 SatoNWnt inhibitor Dickkopf-1 as a target for passive cancer immunotherapyCancer Res.201070135326361:CAS:528:DC%2BC3cXot1Wlu7c%3D10.1158/0008-5472.CAN-09-3879 QiaoYSerum gp73 is also a biomarker for diagnosing cirrhosis in population with chronic HBV infectionClin. Biochem.20144716–17216221:CAS:528:DC%2BC2cXhsV2nsbzF10.1016/j.clinbiochem.2014.08.010 Vongsuvanh, R. et al. Midkine Increases Diagnostic Yield in AFP Negative and NASH-Related Hepatocellular Carcinoma. Avila MA, editor. PLoS One11(5), e0155800 (2016). QinQFWengJXuGXChenCMJiaCKCombination of serum tumor markers dickkopf-1, DCP and AFP for the diagnosis of primary hepatocellular carcinomaAsian Pac. J. Trop. Med.2017104409131:CAS:528:DC%2BC2sXlvFWksrw%3D10.1016/j.apjtm.2017.03.016 Yao, M. et al. The Clinical Significance of GP73 in Immunologically Mediated Chronic Liver Diseases: Experimental Data and Literature Review. Clin. Rev. Allergy. (2018). JangESDiagnostic Performance of Alpha-Fetoprotein, Protein Induced by Vitamin K Absence, Osteopontin, Dickkopf-1 and Its Combinations for Hepatocellular CarcinomaPlos One2011113e015106910.1371/journal.pone.0151069 Li, B. et al. The Clinical Values of Serum Markers in the Early Prediction of Hepatocellular Carcinoma. Biomed. Res. Int. 5358615, (2017). El-SeragHBEpidemiology of viral hepatitis and hepatocellular carcinomaGastroenterology20121421264127310.1053/j.gastro.2011.12.061 LiDMalloryTSatomuraSAFP-L3: A new generation of tumor marker for hepatocellular carcinomaClin. Chim. Acta20013131–21591:CAS:528:DC%2BD3MXnvFGqtLo%3D10.1016/S0009-8981(01)00644-1 L Tian (62051_CR21) 2011; 129 Y Mao (62051_CR22) 2010; 59 AP Barreiros (62051_CR14) 2012; 57 62051_CR23 A Colli (62051_CR3) 2006; 101 HB El-Serag (62051_CR2) 2012; 142 A Maitra (62051_CR9) 2004; 99 62051_CR16 62051_CR13 62051_CR1 T Liu (62051_CR26) 2017; 8 62051_CR6 T Ge (62051_CR19) 2015; 32 JM Llovet (62051_CR15) 2008; 100 QF Qin (62051_CR7) 2017; 10 P Song (62051_CR4) 2014; 3 WW Zhu (62051_CR17) 2013; 19 ES Jang (62051_CR20) 2011; 11 H Özkan (62051_CR24) 2011; 83 Y Qiao (62051_CR25) 2014; 47 H Hodeib (62051_CR8) 2017; 9 D Li (62051_CR5) 2001; 313 T Liu (62051_CR10) 2017; 8 N Sato (62051_CR11) 2010; 70 Q Yan (62051_CR12) 2012; 11 Q Shen (62051_CR18) 2012; 13 |
References_xml | – reference: SatoNWnt inhibitor Dickkopf-1 as a target for passive cancer immunotherapyCancer Res.201070135326361:CAS:528:DC%2BC3cXot1Wlu7c%3D10.1158/0008-5472.CAN-09-3879 – reference: GeTDiagnostic values of alpha-fetoprotein, dickkopf-1, and osteopontin for hepatocellular carcinomaMed. Oncol.201532310.1007/s12032-014-0367-z – reference: QinQFWengJXuGXChenCMJiaCKCombination of serum tumor markers dickkopf-1, DCP and AFP for the diagnosis of primary hepatocellular carcinomaAsian Pac. J. Trop. Med.2017104409131:CAS:528:DC%2BC2sXlvFWksrw%3D10.1016/j.apjtm.2017.03.016 – reference: LiDMalloryTSatomuraSAFP-L3: A new generation of tumor marker for hepatocellular carcinomaClin. Chim. Acta20013131–21591:CAS:528:DC%2BD3MXnvFGqtLo%3D10.1016/S0009-8981(01)00644-1 – reference: SongPTangWKokudoNSerum biomarkers for early diagnosis of hepatocellular carcinomaTransl. Gastrointest. Cancer20143210351:CAS:528:DC%2BC28Xhtlyiu7vO – reference: Shaheen, K. Y. A., Abdel-Mageed, A. I., Safwat, E., Albreedy, A. M. The value of serum midkine level in diagnosis of hepatocellular carcinoma. Int. J. Hepatol. 1–5, (2015). – reference: JangESDiagnostic Performance of Alpha-Fetoprotein, Protein Induced by Vitamin K Absence, Osteopontin, Dickkopf-1 and Its Combinations for Hepatocellular CarcinomaPlos One2011113e015106910.1371/journal.pone.0151069 – reference: Li, B. et al. The Clinical Values of Serum Markers in the Early Prediction of Hepatocellular Carcinoma. Biomed. Res. Int. 5358615, (2017). – reference: ColliAAccuracy of Ultrasonography, Spiral CT, Magnetic Resonance, and Alpha-Fetoprotein in Diagnosing Hepatocellular Carcinoma: A Systematic Review: CMEAm. J. Gastroenterol.20061013513231:CAS:528:DC%2BD28XjtlGhsLs%3D10.1111/j.1572-0241.2006.00467.x – reference: MaoYGolgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinomaGut201059121687931:CAS:528:DC%2BC3MXpvFCr10.1136/gut.2010.214916 – reference: El-SeragHBEpidemiology of viral hepatitis and hepatocellular carcinomaGastroenterology20121421264127310.1053/j.gastro.2011.12.061 – reference: Ferlay, J. et al. Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Lyon, France. GLOBOCAN v1.0. Int Agency Res Cancer. Available from: http://globocan.iarc.fr (2012). – reference: LiuTSerum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinomaOncotarget201781016498506281577055369980 – reference: YanQNovel functional proteins interact with midkine in hepatic cancer cellsHepatobiliary Pancreat. Dis. Int.2012113272714161941:CAS:528:DC%2BC38XhtFWhtL%2FF10.1016/S1499-3872(12)60160-X – reference: ShenQSerum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: A large-scale, multicentre studyLancet Oncol.2012138817261:CAS:528:DC%2BC38XhtFajsLnK10.1016/S1470-2045(12)70233-4 – reference: LlovetJMDesign and endpoints of clinical trials in hepatocellular carcinomaJ. Natl Cancer Inst.20081001069871110.1093/jnci/djn134 – reference: ZhuWWEvaluation of midkine as a diagnostic serum biomarker in hepatocellular carcinomaClin. Cancer Res.201319143944541:CAS:528:DC%2BC3sXhtFSrtbfP10.1158/1078-0432.CCR-12-3363 – reference: HodeibHELshoraOSelimAMohammed SabryNMohamed EL-ashryHSerum Midkine and Osteopontin Levels as Diagnostic Biomarkers of Hepatocellular CarcinomaElectron. physician2017913492810.19082/3492 – reference: ÖzkanHDiagnostic and Prognostic Validity of Golgi Protein 73 in Hepatocellular CarcinomaDigestion2011831–283810.1159/000320379 – reference: Vongsuvanh, R. et al. Midkine Increases Diagnostic Yield in AFP Negative and NASH-Related Hepatocellular Carcinoma. Avila MA, editor. PLoS One11(5), e0155800 (2016). – reference: TianLSerological AFP/Golgi protein 73 could be a new diagnostic parameter of hepatic diseasesInt. J. Cancer201112981923311:CAS:528:DC%2BC3MXhtVKlsrrK10.1002/ijc.25838 – reference: QiaoYSerum gp73 is also a biomarker for diagnosing cirrhosis in population with chronic HBV infectionClin. Biochem.20144716–17216221:CAS:528:DC%2BC2cXhsV2nsbzF10.1016/j.clinbiochem.2014.08.010 – reference: BarreirosAPPiscagliaFDietrichCFContrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma (HCC): Comments on AASLD guidelinesJ. Hepatol.2012574930210.1016/j.jhep.2012.04.018 – reference: Yao, M. et al. The Clinical Significance of GP73 in Immunologically Mediated Chronic Liver Diseases: Experimental Data and Literature Review. Clin. Rev. Allergy. (2018). – reference: MaitraAThuluvathPJGP73 and liver disease: a (Golgi) complex enigmaAm. J. Gastroenterol.20049961096810.1111/j.1572-0241.2004.40410.x – volume: 11 start-page: 272 issue: 3 year: 2012 ident: 62051_CR12 publication-title: Hepatobiliary Pancreat. Dis. Int. doi: 10.1016/S1499-3872(12)60160-X – volume: 9 start-page: 3492 issue: 1 year: 2017 ident: 62051_CR8 publication-title: Electron. physician doi: 10.19082/3492 – volume: 13 start-page: 817 issue: 8 year: 2012 ident: 62051_CR18 publication-title: Lancet Oncol. doi: 10.1016/S1470-2045(12)70233-4 – volume: 47 start-page: 216 issue: 16–17 year: 2014 ident: 62051_CR25 publication-title: Clin. Biochem. doi: 10.1016/j.clinbiochem.2014.08.010 – volume: 101 start-page: 513 issue: 3 year: 2006 ident: 62051_CR3 publication-title: Am. J. Gastroenterol. doi: 10.1111/j.1572-0241.2006.00467.x – volume: 313 start-page: 15 issue: 1–2 year: 2001 ident: 62051_CR5 publication-title: Clin. Chim. Acta doi: 10.1016/S0009-8981(01)00644-1 – volume: 99 start-page: 1096 issue: 6 year: 2004 ident: 62051_CR9 publication-title: Am. J. Gastroenterol. doi: 10.1111/j.1572-0241.2004.40410.x – volume: 129 start-page: 1923 issue: 8 year: 2011 ident: 62051_CR21 publication-title: Int. J. Cancer doi: 10.1002/ijc.25838 – volume: 8 start-page: 16498 issue: 10 year: 2017 ident: 62051_CR26 publication-title: Oncotarget doi: 10.18632/oncotarget.14954 – volume: 142 start-page: 1264 year: 2012 ident: 62051_CR2 publication-title: Gastroenterology doi: 10.1053/j.gastro.2011.12.061 – volume: 59 start-page: 1687 issue: 12 year: 2010 ident: 62051_CR22 publication-title: Gut doi: 10.1136/gut.2010.214916 – ident: 62051_CR6 doi: 10.1007/s12016-017-8655-y – volume: 10 start-page: 409 issue: 4 year: 2017 ident: 62051_CR7 publication-title: Asian Pac. J. Trop. Med. doi: 10.1016/j.apjtm.2017.03.016 – volume: 100 start-page: 698 issue: 10 year: 2008 ident: 62051_CR15 publication-title: J. Natl Cancer Inst. doi: 10.1093/jnci/djn134 – volume: 8 start-page: 16498 issue: 10 year: 2017 ident: 62051_CR10 publication-title: Oncotarget doi: 10.18632/oncotarget.14954 – ident: 62051_CR16 doi: 10.1155/2015/146389 – volume: 83 start-page: 83 issue: 1–2 year: 2011 ident: 62051_CR24 publication-title: Digestion doi: 10.1159/000320379 – volume: 32 issue: 3 year: 2015 ident: 62051_CR19 publication-title: Med. Oncol. doi: 10.1007/s12032-014-0367-z – ident: 62051_CR1 – ident: 62051_CR23 doi: 10.1155/2017/5358615 – volume: 70 start-page: 5326 issue: 13 year: 2010 ident: 62051_CR11 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-09-3879 – volume: 11 start-page: e0151069 issue: 3 year: 2011 ident: 62051_CR20 publication-title: Plos One doi: 10.1371/journal.pone.0151069 – volume: 57 start-page: 930 issue: 4 year: 2012 ident: 62051_CR14 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2012.04.018 – volume: 3 start-page: 103 issue: 2 year: 2014 ident: 62051_CR4 publication-title: Transl. Gastrointest. Cancer – volume: 19 start-page: 3944 issue: 14 year: 2013 ident: 62051_CR17 publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-12-3363 – ident: 62051_CR13 doi: 10.1371/journal.pone.0155800 |
SSID | ssj0000529419 |
Score | 2.4016888 |
SecondaryResourceType | review_article |
Snippet | Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death worldwide. The use of alpha fetoprotein (AFP) alone was not an accurate... Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death worldwide. The use of alpha fetoprotein (AFP) alone was not an accurate... |
SourceID | pubmedcentral proquest pubmed crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 5156 |
SubjectTerms | 631/67/1857 692/53/2421 692/53/2423 82 82/1 Adult alpha-Fetoproteins - metabolism Biomarkers Biomarkers, Tumor - blood Biomarkers, Tumor - metabolism Carcinoma, Hepatocellular - blood Carcinoma, Hepatocellular - metabolism Carcinoma, Hepatocellular - pathology Cirrhosis Dkk1 protein Female Golgi apparatus Hepatocellular carcinoma Humanities and Social Sciences Humans Intercellular Signaling Peptides and Proteins - blood Intercellular Signaling Peptides and Proteins - metabolism Liver cancer Liver cirrhosis Liver Neoplasms - blood Liver Neoplasms - metabolism Liver Neoplasms - pathology Male Membrane Proteins - analysis Membrane Proteins - blood Membrane Proteins - metabolism Middle Aged Midkine Midkine - blood Midkine - metabolism multidisciplinary Prognosis Protein Precursors - blood ROC Curve Science Science (multidisciplinary) Sensitivity and Specificity Serum levels |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB5BERIXxLuBgozEjVqNYydOuCAELRUSnKi0t8hx7Dbqylma7YF7f3hnnGyqpaLX2FbizOd5eOxvAD7Q_RHiseOZaC1XOhe8yY3jyrlCOFmVVRPZPn8VxyfqxyJfTBtuw3SscqMTo6Jue0t75AdoWhCAlMD8vPrDqWoUZVenEhr34QFRlxGq9ULPeyyUxVKimu7KpLI8GNBe0Z0yipkyxCMvtu3RLSfz9lnJfxKm0Q4dPYHHkwPJvowSfwr3XHgGD8eSkn-fwxXKna16QvrSMTo7yHrPvnX2_LxfeS722fd-edqxyM_QBc60ZCa07GdHhbkcMwM2UfKGqvDQ0DO0V2s0eBe2C_0pacZu-MQMG--8xLEmsEOqZoZIY5Gu9gWcHB3-_nrMp0oL3Cqt1tw1uii0ym3hm8JgCGKFNkQ2hs-t12nljHJpWWUoR6-Nki3xqkkvbWN8br18CTuhD24XmBG-wpiwUrbJlMNoBP0Jr2XrjE6tKH0CYvO_azvRkFM1jGUd0-GyrEcZ1SijOsqoLhL4OI9ZjSQcd_be24ixnhbkUN_AJ4H3czMuJcqPmOD6y9hHYHxX5XkCr0apz6-TqNlLpdIE9BYe5g5E073dErqzSNet0cut0iyB_Q1ybj7r_7N4ffcs3sCjjFCcStRze7Czvrh0b9E9Wjfv4hq4BnBzDQk priority: 102 providerName: ProQuest – databaseName: Springer Nature HAS Fully OA dbid: AAJSJ link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB6VVkhcEO-mFGQkbtQijp044baClmoluECl3iLHa7dRV86quz1w7w9nxnmgpYDENfYojmc8j4znG4C3VD9COHY8EwvLlc4Fb3LjuHKuEE5WZdVEtM-vxemZmp_n5zuQjbUw8dJ-hLSManq8HfZ-jYaGisEo2MlQkHhxD_YIqh1le282m3-bT39WKHelRDVUyKSy_APxthW641revSH5W5o0Wp-TR_BwcBvZrF_oY9hx4Qnc7xtJ_ngKt8httupIvpeO0Y1B1nn2qbVXV93Kc3HEPnfLi5ZFVIY2cKYlM2HBvrTUjssxs8YhStlQ7x0ivUQrtUEzd23b0F2QPmzXH5hhfaVLpDWBHVMPM5QvFkFqn8HZyfH3j6d86K_ArdJqw12jiwK30Ba-KQwGHlZoQxBj-Nx6nVbOKJeWVYbc89oouSA0NemlbYzPrZfPYTd0we0DM8JXGAlWyjaZchiDoBfhtVw4o1MrSp-AGPe7tgP4OPXAWNYxCS7LuudRjTyqI4_qIoF3E82qh9745-zDkY31cAzXNfojqLUo653Am2kYDxBlRUxw3U2cIzCqq_I8gRc916fXSdTnpVJpAnpLHqYJBM69PRLaywjSrdG3rdIsgaNRcn4t6-9fcfB_01_Cg4ykOpWo7Q5hd3N9416hk7RpXg-n4id4iQxI priority: 102 providerName: Springer Nature |
Title | The possible role of Dickkopf-1, Golgi protein- 73 and Midkine as predictors of hepatocarcinogenesis: a review and an Egyptian study |
URI | https://link.springer.com/article/10.1038/s41598-020-62051-6 https://www.ncbi.nlm.nih.gov/pubmed/32198440 https://www.proquest.com/docview/2380032421 https://www.proquest.com/docview/2381626955 https://pubmed.ncbi.nlm.nih.gov/PMC7083902 |
Volume | 10 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwED_tQ6C9THyOjFEZiTcWiBMnTpAQKqVjqrQJAZX6FjmuvUWrktJ2EnvnD-fOSQpjG0-RYlv5uN_57nK53wG8ovoR4rHzQz7VvpAx94tYGV8Yk3ATZWlWOLbP0-R4LEaTeLIBXbuj9gUubw3tqJ_UeDF78_PH1QdU-PdNyXj6dolGiArFKBAKEWR-sgnbaJkkdTQ4ad39hus7zATP2tqZ25fuwP0ItTgV9Dnkb1N1w_-8-RvlP7lUZ6KOHsBu61uyfgOGh7Bhqkdwr-k2efUYfiEk2LwmJZgZRr8VstqyT6W-uKjn1ueH7HM9OyuZo24oK5_JiKlqyk5K6tllmFriEOV1qEEPLT1HU7ZCW7jQZVWf0aZZLt8xxZpyGLdWVWxIjc4QhMwx2T6B8dHw--DYb5sw-FpIsfJNIZNEilgntkgURieaS0U8ZHheWxlkRgkTpFmIIrZSiWhKlGuRjXShbKxt9BS2qroyz4ApbjMMFzOhi1AYDFTQ1bAymholA81T6wHv3neuW4ZyapQxy12mPErzRlw5iit34soTD16v18wbfo7_zj7oxJh3UMvRacGtjVLjHrxcD6OWUepEVaa-dHM4hn5ZHHuw10h9fbkOLh7Ia3hYTyAG7-sjVXnumLwlOsBZEHpw2CHnz23d_RT7d97Cc9gJCctBhLvfAWytFpfmBTpNq6IHm3Iie7Dd74--jfD4cXj65SueHSSDnvsQ0XO68hv6ZBYC |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIgQXxJtAASPBiVpNYidOkBBCtGVLH6dW2ltwHLuNukqW7laod34Pv5EZJ9lqqeit19jeJDuf55HxfAPwjupHiMeOx1FluFRJxMtEWy6tTSMr8iwvPdvnQTo6kt_HyXgF_gy1MHSsctCJXlFXraFv5BtoWhCAlMD8PP3JqWsUZVeHFhodLHbtxS8M2WafdjZRvu_jeHvr8OuI910FuJFKzrktVZoqmZjUlalGd9tEShOxFl43ToW51dKGWR7jMzulpaiIQ0w4YUrtEuME_u4tuI2GN6RgT43V4psOZc1klPe1OaHINmZoH6mGjWK0GPHP02X7d8WpvXo2858Erbd72w_gfu-wsi8dwh7Cim0ewZ2uheXFY_iNOGPTlnbWxDI6q8haxzZrc3raTh2P1tm3dnJcM88HUTecKcF0U7H9mhqBWaZnOETJIur6Q0tP0D7O0cCembppj0kT17OPTLOuxsav1Q3bou5piGzm6XGfwNGNyOAprDZtY58D05HLMQbNpSljaTH6Qf_FKVFZrUITZS6AaPi_C9PTnlP3jUnh0-8iKzoZFSijwsuoSAP4sFgz7Ug_rp29Noix6BXArLiEawBvF8O4dSkfoxvbnvs5EcaTeZIE8KyT-uJ2Ai1JJmUYgFrCw2IC0YIvjzT1iacHV-hV52EcwPqAnMvH-v9bvLj-Ld7A3dHh_l6xt3Ow-xLuxYToUKCOXYPV-dm5fYWu2bx87fcDgx83vQH_Al07SnI |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrUBcKt6kFDASnKi1SezECRJCwO7SUlhViEq9Bcdrt1FXydLdCvXOr-LXMZPHVktFb73Gdl7z9ni-AXhJ9SOEY8fDYGK4VFHA80hbLq2NAyvSJM1rtM9xvHMgPx9Gh2vwp6uFoWOVnU6sFfWkMrRH3kfTggxICcy-a49F7A9G72Y_OXWQokxr106jYZE9e_4Lw7f5290B0vpVGI6G3z_u8LbDADdSyQW3uYpjJSMTuzzW6HqbQGkC2cLrxik_tVpaP0lDfH-ntBQTwhMTTphcu8g4gfe9AeuKoqIerH8Yjve_LXd4KIcmg7St1PFF0p-jtaSKNorYQpQGHq9aw0su7uWTmv-ka2srOLoDG637yt43_HYX1mx5D242DS3P78Nv5Do2q0jOppbRyUVWOTYozMlJNXM82GafqulRwWp0iKLkTAmmywn7WlBbMMv0HIcodUQ9gGjpMVrLBZrbU1OU1RHp5WL-hmnWVNzUa3XJhtRLDfmc1WC5D-DgWqjwEHplVdrHwHTgUoxIU2nyUFqMhdCbcUpMrFa-CRLnQdD978y0IOjUi2Oa1cl4kWQNjTKkUVbTKIs9eL1cM2sgQK6cvdWRMWvVwTy7YF4PXiyHUZApO6NLW53VcwKMLtMo8uBRQ_Xl4wTalURK3wO1wg_LCQQSvjpSFsc1WLhCHzv1Qw-2O865eK3_f8Xm1V_xHG6h8GVfdsd7T-B2SAztC1S4W9BbnJ7Zp-inLfJnrUAw-HHdMvgXcKxQDQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+possible+role+of+Dickkopf-1%2C+Golgi+protein-+73+and+Midkine+as+predictors+of+hepatocarcinogenesis%3A+a+review+and+an+Egyptian+study&rft.jtitle=Scientific+reports&rft.au=N+Zekri%2C+Abdel-Rahman&rft.au=El+Kassas%2C+Mohamed&rft.au=Salam%2C+El+SayedTarekAbd+El&rft.au=Hassan%2C+Reem+Mostafa&rft.date=2020-03-20&rft.eissn=2045-2322&rft.volume=10&rft.issue=1&rft.spage=5156&rft_id=info:doi/10.1038%2Fs41598-020-62051-6&rft_id=info%3Apmid%2F32198440&rft.externalDocID=32198440 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon |